CClinicalTrials.gg
CompletedNCT07162922Updated Dec 29, 2025

Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomy

An interventional study of 8 mmHg pressure group and 14 mmHg pressure group in Increased Intracranial Pressure Disorders, Perioperative Complication and Pneumoperitoneum, sponsored by Engin Çetin. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by Engin Çetin · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Purpose The goal of this clinical trial is to learn how different intra-abdominal pressures during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which is a non-invasive marker of intracranial pressure. The study will also evaluate whether these changes are related to symptoms such as headache, confusion, and nausea after surgery.

Study Design

This is a prospective, randomized, double-blind clinical trial. Patients undergoing elective laparoscopic cholecystectomy will be assigned to one of two groups:

Group 1: pneumoperitoneum at 8 mmHg Group 2: pneumoperitoneum at 14 mmHg ONSD will be measured at several time points before, during, and after surgery using transorbital ultrasonography.

Read the detailed description

Purpose The aim of this clinical trial is to investigate how different intra-abdominal pressures applied during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which serves as a reliable, non-invasive marker of intracranial pressure. The study also seeks to determine whether perioperative ONSD changes are associated with postoperative symptoms such as headache, nausea, and disorientation, as well as with recovery parameters and hemodynamic stability.

Study Design

This is a prospective, randomized, double-blind, interventional clinical trial. Eligible patients scheduled for elective laparoscopic cholecystectomy will be randomized into two groups based on pneumoperitoneum pressure:

Group 1 (Low-pressure group): pneumoperitoneum maintained at 8 mmHg Group 2 (High-pressure group): pneumoperitoneum maintained at 14 mmHg

ONSD will be measured via transorbital ultrasonography at standardized perioperative time points:

T0: Before induction of anesthesia

T1: 30 minutes after initiation of pneumoperitoneum

T2: 5 minutes after extubation

T3: 1 hour postoperatively

T4: 2 hours postoperatively

All ultrasonographic assessments will be performed by a trained investigator blinded to the patient's group allocation.

Participation Patients will receive anesthesia and undergo laparoscopic cholecystectomy according to standard surgical protocols.

Each participant will be randomly assigned to one of the two pneumoperitoneum pressure groups (8 mmHg or 14 mmHg).

After surgery, patients will be observed in the recovery unit. Postoperative symptoms including headache, nausea and vomiting will be recorded.

02

Conditions studied

  • Increased Intracranial Pressure Disorders
  • Perioperative Complication
  • Pneumoperitoneum

Browse trials for

Keywords

  • optic nerve sheath,
  • ultrasonography,
  • cholesistectomy,
  • pneumoperitoneum
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18-65 years of age
  • ASA physical status I-II
  • BMI \< 30 kg/m²
  • Scheduled for elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion Criteria:

  • Known neurological diseases
  • Ocular pathology
  • History of elevated intracranial pressure (ICP)
  • Pregnancy
  • Need for emergency surgery
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
76 participants (actual)

Study arms

  • Active comparator
    8 mmHg pressure group

    Patients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 8 mmHg.

    Other: 8 mmHg pressure group

  • Active comparator
    14 mmHg pressure group

    Patients in this group will undergo laparoscopic cholecystectomy with pneumoperitoneum maintained at 14 mmHg.

    Other: 14 mmHg pressure group

Interventions

  • Other8 mmHg pressure group

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 8 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

  • Other14 mmHg pressure group

    Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 14 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

05

What researchers measure

Primary outcomes

  1. Effects of Pneumoperitoneum Pressure on ONSD Over Time

    To compare the effect of two different pneumoperitoneum pressures (8 mmHg vs. 14 mmHg) on optic nerve sheath diameter (ONSD) during laparoscopic cholecystectomy. ONSD will be assessed by measuring changes with transorbital ultrasonography at multiple perioperative time points

    Time frame: T0: Before intubation T1: 30 minutes after the initiation of pneumoperitoneum T2: 5 minutes after extubation T3: 1 hour after extubation T4: 2 hours after extubation

Secondary outcomes

  1. Number of participants with postoperative nausea assessed by a standardized 4-point nausea scale

    Postoperative nausea will be assessed one hour after surgery using a standardized 4-point scale (0 = no nausea, 1 = mild, 2 = moderate, 3 = severe). The number and proportion of participants with any nausea (score ≥1) will be recorded. Higher scores indicate worse symptoms.

    Time frame: One hour after surgery

  2. Number of participants with postoperative vomiting within one hour after surgery

    Occurrence of vomiting will be recorded during the first postoperative hour. The number and percentage of participants experiencing at least one vomiting episode will be documented (yes/no outcome)

    Time frame: One hour after surgery

  3. Severity of postoperative headache assessed by Numerical Rating Scale (NRS, 0-10)

    Postoperative headache will be evaluated one hour after surgery using a Numerical Rating Scale (NRS), where 0 = no pain and 10 = worst possible pain. Mean NRS scores and the proportion of participants with moderate-to-severe headache (NRS ≥4) will be reported. Higher scores indicate more severe pain.

    Time frame: One hour after surgery

06

Study locations

1 site
  • University of Health Sciences Kocaeli City Hospital
    Kocaeli, Izmit 41100, Turkey (Türkiye)
07

References and documents

Publications

  • Blecha S, Harth M, Schlachetzki F, Zeman F, Blecha C, Flora P, Burger M, Denzinger S, Graf BM, Helbig H, Pawlik MT. Changes in intraocular pressure and optic nerve sheath diameter in patients undergoing robotic-assisted laparoscopic prostatectomy in steep 45 degrees Trendelenburg position. BMC Anesthesiol. 2017 Mar 11;17(1):40. doi: 10.1186/s12871-017-0333-3. PubMed 28284189 ↗
  • Cetin E, Gunel B, Yilmaz M, Ergun A. Dynamic effects of low- and high-pressure pneumoperitoneum on optic nerve sheath diameter during laparoscopic cholecystectomy: a prospective, randomized, observer-blinded clinical trial. BMC Anesthesiol. 2026 Mar 19;26(1):266. doi: 10.1186/s12871-026-03762-7. PubMed 41851846 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT07162922
Lead sponsor
Engin Çetin
Responsible party
Engin Çetin (principal investigator, Kocaeli City Hospital) — Sponsor-investigator
First posted
Sep 9, 2025
Start date
Sep 17, 2025
Primary completion
Dec 21, 2025
Completion
Dec 21, 2025
Last update
Dec 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion